［1］Haap M，Wiefels J，Horger M，et al.Clinical，laboratory and imaging findings in Castleman's disease：The subtype decides［J］.Blood reviews，2018，32(3)：225-234.
［2］Castleman B，Iverson L，Menendez VP.Localized mediastinal lymphnode hyperplasia resembling thymoma［J］.Cancer，1956，9(4)：822-830.
［3］中华医学会血液学分会淋巴细胞疾病学组，中国抗癌协会血液肿瘤专业委员会，中国Castleman病协作组.中国Castleman病诊断与治疗专家共识(2021年版)［J］.中华血液学杂志，2021，42(7)：529-534.
［4］van Rhee F，Voorhees P，Dispenzieri A，et al.International，evidence-based consensus treatment guidelines for idiopathic multicentric castleman disease［J］.Blood，2018，132(20)：2115-2124.
［5］van Rhee F，Oksenhendler E，Srkalovic G，et al.International evidence-based consensus diagnostic and treatment guidelines for unicentric castleman disease［J］.Blood Adv，2020，4(23)：6039-6050.
［6］Kligerman S，Auerbach A，Franks T，et al.Castleman disease of the thorax：clinical，radiologic，and pathologic correlation：From the radiologic pathology archives［J］.Radiographics，2016，36(5)：1309-1332. |
|
|
���������� 14010702070875��